FDA Rejects MDMA for Mental Health Treatment After Identifying Flawed Study Data
CCHR welcomes the FDA’s decision to disapprove the hallucinogenic drug, MDMA (Ecstasy) saying if approved, it would have fueled a planned $12 billion industry to…
Tag Archives: FDA rejects MDMA